Ethyl 4,5-difluoro-1H-indole-2-carboxylate, 100mg

N-(cyanomethyl)acetamide, 1g

2',7'-Dichlorofluorescein [for Fluorescent indicator]>95.0%(HPLC)1g

(methylsulfonyl)acetyl chloride, 1g

Transition piece, 29/32, 45/40, 1 Piece

Dibenzothiophene 5-oxide, 97.0%, 10g

8-Benzyl-N-methyl-8-azabicyclo[3.2.1]octan-3-amine, 98%, 5g

Primine, with analyt. Documents, 20 mg, glass packaging

N-(6-Aminohexyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95.0%, 250mg

N-Boc-2-chloroethylamine, 98.0%, 1g

(1R,2R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclobutane-1-carboxylic acid, 97%, 100mg

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-(2,3-bis(palmitoyloxy)propyl)-L-cysteine, 97%, 10g

(1-tosyl-1H-Indol-3-yl)boronic acid, 95.0%, 250mg